Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Hepatitis Health Center

Font Size

Boceprevir Boosts Hepatitis C Treatment Success

Up to 75% Viral Cure Rate When Boceprevir Added to Standard Therapy
WebMD Health News
Reviewed by Laura J. Martin, MD

Aug. 9, 2010 -- Adding Merck's boceprevir to standard hepatitis C therapy increases the viral cure rate up to 75% -- a success rate similar to that of Vertex's telaprevir.

Standard hepatitis C treatment results in a "cure" less than half the time. It combines alpha interferon with ribavirin, a drug with general antiviral effects. In contrast, boceprevir and telaprevir directly attack the hepatitis C virus (HCV).

Boceprevir and telaprevir each inhibit the HCV protease molecule. Like HIV protease inhibitors, these HCV protease inhibitors are extremely effective at suppressing the virus they target.

Unfortunately, there's another similarity. Like the AIDS virus, the hepatitis virus quickly develops resistance to protease inhibitors. Neither boceprevir nor telaprevir can be given alone -- each must be added to standard combination treatment with alpha interferon and ribavirin.

That standard combination causes a lot of hard-to-tolerate side effects. Both boceprevir and telaprevir add to the side effect burden. Very preliminary evidence suggests that boceprevir may be somewhat easier to take.

Nevertheless, the boceprevir findings are very good news for people with hepatitis C infection. They show the drug greatly increases the odds that treatment will result in a cure -- that is, in HCV dropping to undetectable levels. Patients who achieve such a "sustained viral response" (SVR) or "viral cure" usually don't see the virus come back to harmful levels.

Boceprevir Clinical Trial Results

The boceprevir studies tested the drug in patients with genotype 1 HCV infection. Genotype 1 is the most common HCV strain in the U.S. and is generally considered the most resistant to treatment.

In a phase III clinical trial reported by Merck, among never-before-treated patients:

  • 66% had an SVR with boceprevir plus standard treatment for 48 weeks.
  • 63% had an SVR after four weeks of standard therapy and 44 weeks of boceprevir plus standard therapy.
  • 38% on standard treatment had an SVR.

In another phase III clinical trial reported by Merck, among patients for whom previous treatment failed:

  • 66% had an SVR with boceprevir plus standard treatment for 48 weeks.
  • 59% had an SVR after four weeks of standard therapy and 44 weeks of boceprevir plus standard therapy.
  • 21% on standard treatment had an SVR.

Today on WebMD

Hepatitus C virus
Types, symptoms and treatments.
liver illustration
Myths and facts about this essential organ.
woman eating apple
What you need to know.
doctor and patient
What causes it?
Hepatitis C Treatment
Syringes and graph illustration
liver illustration
passport, pills and vaccine
Scientist looking in microscope
Fatty Liver Disease
Digestive Diseases Liver Transplantation
Picture Of The Liver
Image Collection